Study: New Vaccine Modality Using Biopolymer Particles Shows Promise in Group A Streptococcus
Investigators from Griffith University stated that technology has helped the development of vaccines that are safe to use and induce strong immune responses against Strep A.
United States Shuxiong Chen Bernd Rehm Centers For Disease Griffith Institute For Drug Discovery Groupa Streptococcal
Source: pharmacytimes.com